Inotuzumab ozogamicin Interactions
There are 431 drugs known to interact with inotuzumab ozogamicin, along with 3 disease interactions. Of the total drug interactions, 110 are major, 320 are moderate, and 1 is minor.
- View all 431 medications that may interact with inotuzumab ozogamicin
- View inotuzumab ozogamicin disease interactions (3)
Most frequently checked interactions
View interaction reports for inotuzumab ozogamicin and the medicines listed below.
- Adderall (amphetamine / dextroamphetamine)
- Adderall XR (amphetamine / dextroamphetamine)
- Aleve (naproxen)
- Ambien (zolpidem)
- AndroGel (testosterone)
- Avastin (bevacizumab)
- Belsomra (suvorexant)
- Benadryl (diphenhydramine)
- Calcium 600 D (calcium / vitamin d)
- Claritin (loratadine)
- Creon (pancrelipase)
- Cytoxan (cyclophosphamide)
- Descovy (emtricitabine / tenofovir alafenamide)
- Excedrin (acetaminophen / aspirin / caffeine)
- Hycamtin (topotecan)
- Lioresal (baclofen)
- Lupron (leuprolide)
- MethylPREDNISolone Dose Pack (methylprednisolone)
- Midol (acetaminophen / pamabrom)
- Morphine LP Epidural (morphine)
- Mytesi (crofelemer)
- Neulasta (pegfilgrastim)
- OxyContin (oxycodone)
- PreserVision AREDS 2 (multivitamin with minerals)
- Protonix (pantoprazole)
- Restoril (temazepam)
- Rubraca (rucaparib)
- Rukobia (fostemsavir)
- Taxotere (docetaxel)
- Tivicay (dolutegravir)
Inotuzumab ozogamicin disease interactions
There are 3 disease interactions with inotuzumab ozogamicin which include:
More about inotuzumab ozogamicin
- inotuzumab ozogamicin consumer information
- Compare alternatives
- Side effects
- Dosage information
- During pregnancy
- Drug class: miscellaneous antineoplastics
- Breastfeeding
- En español
Related treatment guides
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.